| Cancer |
CancerType |
Treatment |
Signature |
SearchID |
Experimental |
PMID |
Details |
Boxplot |
Network |
Correlation |
Survival |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | cytochrome c | CYCS | cell lines | 26811457 | Details |  |  |  |  |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | caspase-9 | CASP9 | cell lines | 26811457 | Details | | | | |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | caspase-3 | CASP3 | cell lines | 26811457 | Details | | | | |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | caspase-3 | CASP3 | cell lines | 26811457 | Details | | | | |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | caspase-3 | CASP3 | cell lines | 26811457 | Details | | | | |
| Hodgkin Lymphoma | HL | Brentuximab vedotin | caspase-3 | CASP3 | cell lines | 26811457 | Details | | | | |
| Non Hodgkin Lymphoma | NHL | rituximab | CD20 | MS4A1 | clinical trail | 28097046 | Details | | | | |